A Prospective Pilot Study of Kidney-specific Biomarkers to Detect Acute Kidney Injury After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

Overview

Journal Asian Biomed (Res Rev News)

Date 2024 Dec 19

PMID 39697218

Authors

Chao-Yu Chen

Ting-Yao Wang

Hung-Yu Chang

Min-Chi Chen

Lan-Yan Yang

Affiliations

Soon will be listed here.

Abstract

Background: Acute kidney injury (AKI) is a critical morbidity after cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).

Objective: This study was conducted to investigate the use of kidney-specific biomarkers to evaluate the diagnostic accuracy of post-HIPEC AKI.

Methods: Patients who received CRS/HIPEC were prospectively enrolled in this study. We serially sampled urine neutrophil gelatinase-associated lipocalin (NGAL), serum cystatin C (sCyC), and β2 microglobulin (sβ2-MG) on the day before CRS/HIPEC and then 2 h, 1 d, 2 d, 3 d, and 7 d after CRS/HIPEC. The primary outcome was the occurrence of AKI during the first 7 d. The areas under the receiver operating characteristic curve (AUCs) were calculated to evaluate the detection performance.

Results: A total of 75 patients were eligible, of whom 5 (6.7%) fulfilled the criteria of AKI during the study period (AKI group) and 70 did not (non-AKI group). No significant differences were observed in these biomarkers between the two groups, except for sβ2-MG on day 3 ( = 0.025). Regarding changes in biomarker concentrations, the AKI group had a significantly higher concentration range of sCyC on day 3 ( = 0.009) and sβ2-MG on day 1 and day 3 ( = 0.013 and 0.019).

Conclusions: This is the first prospective study to evaluate the value of kidney-specific biomarkers in patients after CRS/HIPEC. We found that AKI cannot be predicted by simply using the absolute measurements of these biomarkers because of the heterogeneous characteristics of the patients.

References

Zeng X, McMahon G, Brunelli S, Bates D, Waikar S . Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2013; 9(1):12-20. PMC: 3878695. DOI: 10.2215/CJN.02730313. View

Bouhadjari N, Gabato W, Calabrese D, Msika S, Keita H . Hyperthermic intraperitoneal chemotherapy with cisplatin: Amifostine prevents acute severe renal impairment. Eur J Surg Oncol. 2015; 42(2):219-23. DOI: 10.1016/j.ejso.2015.07.016. View

Simkens G, Rovers K, Nienhuijs S, de Hingh I . Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res. 2017; 9:259-266. PMC: 5501638. DOI: 10.2147/CMAR.S119569. View

Chawla L, Eggers P, Star R, Kimmel P . Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014; 371(1):58-66. PMC: 9720902. DOI: 10.1056/NEJMra1214243. View

Ahmad T, Jackson K, Rao V, Tang W, Brisco-Bacik M, Chen H . Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury. Circulation. 2018; 137(19):2016-2028. PMC: 6066176. DOI: 10.1161/CIRCULATIONAHA.117.030112. View

Wang R, Hu H, Hu S, He H, Shui H . β2-microglobulin is an independent indicator of acute kidney injury and outcomes in patients with intracerebral hemorrhage. Medicine (Baltimore). 2020; 99(8):e19212. PMC: 7034650. DOI: 10.1097/MD.0000000000019212. View

Sugarbaker P . Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. Cancer Treat Rev. 2016; 48:42-9. DOI: 10.1016/j.ctrv.2016.06.007. View

Lumlertgul N, Ostermann M, McCorkell S, Van Dellen J, Williams A . Association of plasma and urine NGAL with acute kidney injury after elective colorectal surgery: A cohort study. Ann Med Surg (Lond). 2021; 62:315-322. PMC: 7847815. DOI: 10.1016/j.amsu.2021.01.060. View

Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P . Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8(4):R204-12. PMC: 522841. DOI: 10.1186/cc2872. View

10.

Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L . STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Clin Chem. 2015; 61(12):1446-52. DOI: 10.1373/clinchem.2015.246280. View

11.

Ozkok A, Edelstein C . Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int. 2014; 2014:967826. PMC: 4140112. DOI: 10.1155/2014/967826. View

12.

Arjona-Sanchez A, Cadenas-Febres A, Cabrera-Bermon J, Munoz-Casares F, Casado-Adam A, Sanchez-Hidalgo J . "Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances". Eur J Surg Oncol. 2016; 42(6):869-76. DOI: 10.1016/j.ejso.2015.12.016. View

13.

Song Y, Kim D, Kwon T, Han D, Baik S, Jung H . Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial. Int J Hyperthermia. 2018; 36(1):1-8. DOI: 10.1080/02656736.2018.1526416. View

14.

Chen C, Chang H, Lu C, Chen M, Huang T, Lee L . Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperthermia. 2020; 37(1):1279-1286. DOI: 10.1080/02656736.2020.1846793. View

15.

Schiffl H, Lang S . Update on biomarkers of acute kidney injury: moving closer to clinical impact?. Mol Diagn Ther. 2012; 16(4):199-207. DOI: 10.1007/BF03262209. View

16.

Hei Z, Li X, Shen N, Pang H, Zhou S, Guan J . Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation. Chin Med J (Engl). 2008; 121(14):1251-6. View

17.

Kellum J, Ronco C, Bellomo R . Conceptual advances and evolving terminology in acute kidney disease. Nat Rev Nephrol. 2021; 17(7):493-502. DOI: 10.1038/s41581-021-00410-w. View

18.

Ye Z, Liu H, Zhao B, Fu H, Li Y, Chen L . Correlation and Diagnostic Value of Serum Cys-C, RBP4, and NGAL with the Condition of Patients with Traumatic Acute Kidney Injury. Evid Based Complement Alternat Med. 2021; 2021:4990941. PMC: 8434901. DOI: 10.1155/2021/4990941. View

19.

Albert C, Zapf A, Haase M, Rover C, Pickering J, Albert A . Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2020; 76(6):826-841.e1. PMC: 8283708. DOI: 10.1053/j.ajkd.2020.05.015. View

20.

de Geus H, Betjes M, Bakker J . Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J. 2012; 5(2):102-108. PMC: 3341843. DOI: 10.1093/ckj/sfs008. View